These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 28862190)

  • 1. Seroprevalence of cytomegalovirus in donors & opportunistic viral infections in liver transplant recipients.
    Varghese J; Subramanian S; Reddy MS; Shanmugam N; Balajee G; Srinivasan V; Venkataraman J; Mohamed R
    Indian J Med Res; 2017 Apr; 145(4):558-562. PubMed ID: 28862190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.
    Conde-Glez C; Lazcano-Ponce E; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
    Vaccine; 2013 Oct; 31(44):5067-74. PubMed ID: 24021305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
    Saghafi H; Qorashi M; Heidari A
    Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic significance of enzyme linked immuno-sorbent assay for herpes simplex, varicella zoster and cytomegalovirus retinitis.
    Madhavan HN; Priya K
    Indian J Ophthalmol; 2003 Mar; 51(1):71-5. PubMed ID: 12701866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus in children with acute lymphoblastic leukemia in Egypt.
    Loutfy SA; Alam El-Din HM; Ibrahim MF; Hafez MM
    Saudi Med J; 2006 Aug; 27(8):1139-45. PubMed ID: 16883441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?
    Bruminhent J; Thongprayoon C; Dierkhising RA; Kremers WK; Theel ES; Razonable RR
    Liver Transpl; 2015 Apr; 21(4):539-46. PubMed ID: 25597303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
    Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A
    Transplant Proc; 2005 Sep; 37(7):3182-6. PubMed ID: 16213344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expanding spectrum of herpesvirus infections of the nervous system.
    Kleinschmidt-DeMasters BK; Gilden DH
    Brain Pathol; 2001 Oct; 11(4):440-51. PubMed ID: 11556690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of viral cerebrospinal fluid PCR testing for diagnosis of central nervous system disorders: a retrospective 11-year experience.
    Kleines M; Scheithauer S; Schiefer J; Häusler M
    Diagn Microbiol Infect Dis; 2014 Nov; 80(3):207-15. PubMed ID: 25178670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoproliferative response to herpes simplex virus type 1, cytomegalovirus, Epstein-Barr virus, varicella zoster virus, human herpes virus 6, 7, and 8 antigen stimulation in pediatric allogeneic stem cell transplant recipients.
    Cheng FW; Chan PK; Lee V; Leung WK; Shing MK; Li CK; Leung TF
    Pediatr Transplant; 2010 Sep; 14(6):761-9. PubMed ID: 20534025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shedding of HSV-1, HSV-2, CMV, and EBV in the saliva of hematopoietic stem cell transplant recipients at Fundación HOMI - Hospital de la Misericordia, Bogotá, D.C.
    Bohórquez SP; Díaz J; Rincón CM; Estupiñán M; Chaparro M; Low-Calle AM; Castellanos JE
    Biomedica; 2016 May; 36(0):201-10. PubMed ID: 27622810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-specific antibodies to Epstein-Barr virus, varicella-zoster virus and rubella virus in renal transplant patients with cytomegalovirus infections.
    O'Neill HJ; Shirodaria PV
    J Infect; 1992 May; 24(3):301-9. PubMed ID: 1318341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].
    Merlino C
    G Batteriol Virol Immunol; 1991; 84(1-12):41-52. PubMed ID: 1668971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Preemptive Therapy and Antiviral Prophylaxis for Prevention of Cytomegalovirus in Seropositive Liver Transplant Recipients.
    Liu AW; Jutivorakool K; Fisher CE; Rakita RM; Reyes JD; Bhattacharya RB; Jerome KR; Limaye AP
    Transplantation; 2018 Apr; 102(4):632-639. PubMed ID: 29215460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of herpesviridae and hepatitis B virus DNA in the liver of patients with non-A, non-B fulminant hepatic failure.
    Mason A; Sallie R; Perrillo R; Rayner A; Xu L; Dohner DE; Dehner M; Naoumov N; Gelb L; Saha B; O'Grady J; Williams R
    Hepatology; 1996 Dec; 24(6):1361-5. PubMed ID: 8938162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of cytomegalovirus, human parvovirus B19, and herpes simplex virus-1/2 in women with first-trimester spontaneous abortions.
    Zhou Y; Bian G; Zhou Q; Gao Z; Liao P; Liu Y; He M
    J Med Virol; 2015 Oct; 87(10):1749-53. PubMed ID: 25976377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral prophylaxis in organ transplant patients.
    Slifkin M; Doron S; Snydman DR
    Drugs; 2004; 64(24):2763-92. PubMed ID: 15563248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of herpes viruses in children with acute appendicitis.
    Katzoli P; Sakellaris G; Ergazaki M; Charissis G; Spandidos DA; Sourvinos G
    J Clin Virol; 2009 Apr; 44(4):282-6. PubMed ID: 19233720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infrequent detection of cytomegalovirus and Epstein-Barr virus DNA in synovial membrane of patients with rheumatoid arthritis.
    Mousavi-Jazi M; Boström L; Lövmark C; Linde A; Brytting M; Sundqvist VA
    J Rheumatol; 1998 Apr; 25(4):623-8. PubMed ID: 9558160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-transplant cytomegalovirus immunoglobulin G antibody levels could prevent severe cytomegalovirus infections post-transplant in liver transplant recipients: Experience from a tertiary care liver centre.
    Gupta E; Pamecha V; Verma Y; Kumar N; Rastogi A; Hasnian N; Bhadoria AS
    Indian J Med Microbiol; 2017; 35(4):499-503. PubMed ID: 29405140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.